Castle Biosciences
CSTL
CSTL
151 hedge funds and large institutions have $553M invested in Castle Biosciences in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 53 increasing their positions, 56 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% less call options, than puts
Call options by funds: $3.06M | Put options by funds: $3.33M
1% less funds holding
Funds holding: 153 → 151 (-2)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
151
Holding in Top 10
1
Calls
$3.06M
Puts
$3.33M
Top Buyers
| 1 | +$15.5M | |
| 2 | +$7.24M | |
| 3 | +$6.97M | |
| 4 |
BlackRock
New York
|
+$6.92M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.65M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$10.4M | |
| 3 | -$6.76M | |
| 4 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
-$2.27M |
| 5 |
KOCAA
Knights of Columbus Asset Advisors
New Haven,
Connecticut
|
-$1.8M |